Top 100 Contractors in NAICS 325414: Biological Product (except Diagnostic) Manufacturing, FY2021

Parent companies by net contract obligations Oct 1, 2020 – Sep 30, 2021 Code page on GovTribe

The top 10 won 99% of FY2021 NAICS 325414 contract dollars

Ranking facts

Contract obligations
$29,614,835,947 Net of deobligations, by contracts coded NAICS 325414
Contractors
184 Parent companies with an obligation
Largest contractor
Pfizer Inc. $23.1 billion, 77.8% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $23,131,122,560
Rank history: #1 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
2 $5,564,999,936
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
3
Modernatx Inc.
$443,210,908
Rank history: #2 in FY2022, #2 in FY2023 and not on the FY2024–FY2025 lists; down 2 since FY2020.
4 $182,935,371
Rank history: #4 in FY2022, #1 in FY2023 and not on the FY2024–FY2025 lists; down 2 since FY2020.
5
Merck & Co. Inc. 2 awardees, including Merck Sharp & Dohme LLC
$105,400,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
6 $52,536,857
Rank history: #5 in FY2022, #5 in FY2023, #7 in FY2024 and not on the FY2025 list; up 2 since FY2020.
7 $34,953,404
Rank history: not on the FY2022–FY2023 lists, #5 in FY2024 and #5 in FY2025; new, not ranked in FY2020.
8 $19,938,662
Rank history: #6 in FY2022, #4 in FY2023 and not on the FY2024–FY2025 lists; down 2 since FY2020.
9 $13,609,381
Rank history: #26 in FY2022 and not on the FY2023–FY2025 lists; down 2 since FY2020.
10 $10,000,000
Rank history: not on the FY2022–FY2025 lists; down 7 since FY2020.
11
Catalent Indiana LLC
$6,640,000
Rank history: not on the FY2022–FY2025 lists; up 8 since FY2020.
12 $4,199,162
Rank history: #7 in FY2022, #12 in FY2023, #52 in FY2024 and not on the FY2025 list; up 4 since FY2020.
13 $3,632,808
Rank history: #8 in FY2022, #8 in FY2023, #12 in FY2024 and #7 in FY2025; up 2 since FY2020.
14 $3,162,500
Rank history: #18 in FY2022, #9 in FY2023, not on the FY2024 list and #11 in FY2025; down 2 since FY2020.
15 $2,684,074
Rank history: #30 in FY2022, #27 in FY2023, #46 in FY2024 and #39 in FY2025; down 11 since FY2020.
16 $2,575,609
Rank history: #12 in FY2022, #46 in FY2023, #36 in FY2024 and #75 in FY2025; down 2 since FY2020.
17 $2,202,245
Rank history: #9 in FY2022, #6 in FY2023, #24 in FY2024 and not on the FY2025 list; down 12 since FY2020.
18 $2,057,054
Rank history: #10 in FY2022, #11 in FY2023, #13 in FY2024 and #12 in FY2025; unchanged since FY2020.
19 $1,585,940
Rank history: #13 in FY2022, #10 in FY2023, #17 in FY2024 and #17 in FY2025; up 3 since FY2020.
20
Miltenyi Biotec, Inc.
$1,549,596
Rank history: #20 in FY2022 and not on the FY2023–FY2025 lists; up 9 since FY2020.
21
Glaxosmithkline LLC 2 awardees
$1,544,936
Rank history: #79 in FY2022, #13 in FY2023, #4 in FY2024 and #3 in FY2025; down 10 since FY2020.
22 $1,510,205
Rank history: not on the FY2022–FY2025 lists; down 2 since FY2020.
23 $1,188,789
Rank history: #40 in FY2022, not on the FY2023 list, #82 in FY2024 and not on the FY2025 list; up 42 since FY2020.
24 $1,162,246
Rank history: #16 in FY2022, #14 in FY2023, #18 in FY2024 and #45 in FY2025; up 16 since FY2020.
25 $1,104,677
Rank history: #19 in FY2022, not on the FY2023 list, #27 in FY2024 and #19 in FY2025; down 2 since FY2020.
26 $1,014,417
Rank history: #3 in FY2022, #3 in FY2023, #6 in FY2024 and #10 in FY2025; down 9 since FY2020.
27 $903,101
Rank history: #25 in FY2022, #35 in FY2023, #42 in FY2024 and not on the FY2025 list; down 2 since FY2020.
28 $799,875
Rank history: #23 in FY2022, #7 in FY2023, #10 in FY2024 and #6 in FY2025; new, not ranked in FY2020.
29 $780,764
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
30 $777,151
Rank history: #94 in FY2022, #21 in FY2023, #19 in FY2024 and #13 in FY2025; down 6 since FY2020.
31 $728,131
Rank history: #44 in FY2022, #51 in FY2023 and not on the FY2024–FY2025 lists; up 4 since FY2020.
32
Heyl Chemisch-Pharmazeutische Fabrik GMBH & Co. KG Through Heyltex Corporation
$554,637
Rank history: not on the FY2022–FY2025 lists; up 6 since FY2020.
33 $547,025
Rank history: #27 in FY2022, #22 in FY2023, not on the FY2024 list and #27 in FY2025; new, not ranked in FY2020.
34 $541,517
Rank history: #34 in FY2022, #28 in FY2023, #20 in FY2024 and not on the FY2025 list; new, not ranked in FY2020.
35 $532,666
Rank history: #22 in FY2022, #24 in FY2023, #45 in FY2024 and #48 in FY2025; down 7 since FY2020.
36 $515,609
Rank history: not on the FY2022 list, #29 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
37 $489,800
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
38 $469,209
Rank history: not on the FY2022–FY2025 lists; down 8 since FY2020.
39 $432,402
Rank history: #24 in FY2022, #20 in FY2023 and not on the FY2024–FY2025 lists; down 13 since FY2020.
40 $388,846
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
41 $379,504
Rank history: #39 in FY2022, #42 in FY2023, #54 in FY2024 and #79 in FY2025; up 42 since FY2020.
42 $354,370
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
43 $343,760
Rank history: #43 in FY2022, #78 in FY2023 and not on the FY2024–FY2025 lists; up 119 since FY2020.
44 $325,191
Rank history: #36 in FY2022, #36 in FY2023, #33 in FY2024 and not on the FY2025 list; up 19 since FY2020.
45 $310,470
Rank history: not on the FY2022–FY2023 lists, #84 in FY2024 and #43 in FY2025; up 23 since FY2020.
46 $286,635
Rank history: not on the FY2022–FY2025 lists; unchanged since FY2020.
47 $285,875
Rank history: #21 in FY2022, #17 in FY2023, #40 in FY2024 and not on the FY2025 list; down 15 since FY2020.
48 $277,806
Rank history: not on the FY2022 list, #93 in FY2023 and not on the FY2024–FY2025 lists; up 40 since FY2020.
49 $256,275
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
50 $250,000
Rank history: #67 in FY2022, #53 in FY2023, #50 in FY2024 and #56 in FY2025; up 10 since FY2020.
51 $249,979
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
52 $213,128
Rank history: #38 in FY2022, #65 in FY2023, #38 in FY2024 and #53 in FY2025; up 18 since FY2020.
53 $206,784
Rank history: not on the FY2022 list, #23 in FY2023, #49 in FY2024 and #22 in FY2025; down 20 since FY2020.
54 $205,953
Rank history: not on the FY2022–FY2023 lists, #16 in FY2024 and #15 in FY2025; up 124 since FY2020.
55 $204,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
56 $202,503
Rank history: #42 in FY2022, #34 in FY2023, #35 in FY2024 and #34 in FY2025; down 9 since FY2020.
57 $201,750
Rank history: #35 in FY2022, #25 in FY2023, #32 in FY2024 and not on the FY2025 list; down 21 since FY2020.
58 $187,923
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
59
VWR International LLC 2 awardees
$187,866
Rank history: #90 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
60 $182,740
Rank history: #33 in FY2022, #18 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
61 $168,460
Rank history: #49 in FY2022, #30 in FY2023, #43 in FY2024 and not on the FY2025 list; up 30 since FY2020.
62 $166,800
Rank history: #46 in FY2022, #55 in FY2023, #53 in FY2024 and #51 in FY2025; down 10 since FY2020.
63 $148,769
Rank history: #58 in FY2022, #61 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
64
Horizon Discovery Biosciences Limited 2 awardees, including Dharmacon, Inc.
$141,156
Rank history: #92 in FY2022, #49 in FY2023 and not on the FY2024–FY2025 lists; down 13 since FY2020.
65 $130,500
Rank history: not on the FY2022–FY2025 lists; up 50 since FY2020.
66 $125,000
Rank history: #55 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
67
American Type Culture Collection
$123,716
Rank history: #50 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
68 $123,041
Rank history: #53 in FY2022, #72 in FY2023, #31 in FY2024 and #49 in FY2025; down 20 since FY2020.
69 $120,961
Rank history: #56 in FY2022, #81 in FY2023, #59 in FY2024 and not on the FY2025 list; down 13 since FY2020.
70 $118,465
Rank history: #83 in FY2022 and not on the FY2023–FY2025 lists; up 96 since FY2020.
71 $113,920
Rank history: #11 in FY2022 and not on the FY2023–FY2025 lists; up 1 since FY2020.
72 $108,605
Rank history: #15 in FY2022, #37 in FY2023, #51 in FY2024 and #99 in FY2025; up 17 since FY2020.
73 $105,275
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
74
Chembio Diagnostics Inc. Through Chembio Diagnostic Systems Inc.
$100,995
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
75 $99,000
Rank history: #66 in FY2022, #45 in FY2023, #47 in FY2024 and #44 in FY2025; down 1 since FY2020.
76 $95,120
Rank history: not on the FY2022–FY2025 lists; down 3 since FY2020.
77
Merck KG AUF Aktien 2 awardees, including Sigma-Aldrich, Inc. and EMD Millipore Corp
$92,196
Rank history: #69 in FY2022, #80 in FY2023 and not on the FY2024–FY2025 lists; down 32 since FY2020.
78 $89,538
Rank history: #45 in FY2022, not on the FY2023–FY2024 lists and #90 in FY2025; down 9 since FY2020.
79
Takara Holdings Inc. Through Takara Bio Usa, Inc.
$88,263
Rank history: #80 in FY2022, not on the FY2023 list, #64 in FY2024 and not on the FY2025 list; down 3 since FY2020.
80 $86,500
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
81 $84,100
Rank history: not on the FY2022–FY2023 lists, #81 in FY2024 and not on the FY2025 list; new, not ranked in FY2020.
82 $81,500
Rank history: #41 in FY2022 and not on the FY2023–FY2025 lists; up 54 since FY2020.
83 $79,206
Rank history: #61 in FY2022, #68 in FY2023 and not on the FY2024–FY2025 lists; down 6 since FY2020.
84 $77,800
Rank history: #47 in FY2022 and not on the FY2023–FY2025 lists; down 29 since FY2020.
85 $76,855
Rank history: #62 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
86 $74,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
87 $73,789
Rank history: #52 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
88 $73,735
Rank history: #32 in FY2022, #48 in FY2023, #23 in FY2024 and #30 in FY2025; up 20 since FY2020.
89 $72,954
Rank history: not on the FY2022–FY2025 lists; up 80 since FY2020.
90 $72,683
Rank history: not on the FY2022–FY2025 lists; up 41 since FY2020.
91 $71,400
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
92 $70,000
Rank history: #72 in FY2022 and not on the FY2023–FY2025 lists; up 31 since FY2020.
93 $68,539
Rank history: #63 in FY2022, #32 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
94 $68,523
Rank history: not on the FY2022–FY2025 lists; down 7 since FY2020.
95 $67,020
Rank history: #74 in FY2022 and not on the FY2023–FY2025 lists; up 6 since FY2020.
96 $66,844
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
97
A B C a M PLC Through Abcam Inc.
$66,401
Rank history: #75 in FY2022, #84 in FY2023 and not on the FY2024–FY2025 lists; down 44 since FY2020.
98 $64,538
Rank history: not on the FY2022–FY2023 lists, #94 in FY2024 and not on the FY2025 list; new, not ranked in FY2020.
99 $64,320
Rank history: #78 in FY2022, #85 in FY2023, #100 in FY2024 and not on the FY2025 list; new, not ranked in FY2020.
100 $53,862
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
Show 75 more

100 of 184 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $29.7 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2021 ran Oct 1, 2020 – Sep 30, 2021. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2020. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2020 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 325414 contractors in FY2021?

1. Pfizer Inc. ($23.1B), 2. Regeneron Pharmaceuticals Inc. ($5.56B), 3. Modernatx Inc. ($443M), 4. Emergent Biosolutions Inc. ($183M), 5. Merck & Co. Inc. ($105M), 6. Valneva ($52.5M), 7. Seqirus Inc. ($35M), 8. Boehringer Ingelheim Corporation ($19.9M), 9. Marathon Medical Corporation ($13.6M), 10. Retractable Technologies Inc. ($10M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work